about
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapyDiagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy.Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients.Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals.Pregnancy outcomes in women with advanced HIV infection in Italy.Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy.Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes.Effects of antiretroviral therapy on tube-like network formation of human endothelial cells.Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors.Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study.Percentage and determinants of missed HIV testing in pregnancy: a survey of women delivering in the Lazio region, Italy.Pregnancy outcomes in HIV-infected women of advanced maternal age.Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (AtazanaEffect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART.Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1.Plasma lipid profile in pregnant women with HIV receiving nevirapine.Myelomeningocele in a child with intrauterine exposure to efavirenz.Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia.Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy.Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero.Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women.Lower hemoglobin levels in human immunodeficiency virus-infected patients with a positive direct antiglobulin test (DAT): relationship with DAT strength and clinical stages.Mother to child human immunodeficiency virus (HIV) transmission: what HIV-infected women think. Our experience in Rome, Italy.Body mass index and weight gain in pregnant women with HIV: a national study in Italy.Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.Voluntary pregnancy termination among women with HIV in the HAART era (2002-2008): a case series from a national study.Glucose plasma levels and pregnancy outcomes in women with HIV.Lipid profile during pregnancy in HIV-infected women.Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimensFactors Influencing Gestational Age-Adjusted Birthweight in a National Series of 600 Newborns from Mothers with HIVIn utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothersPregnancy outcomes and antiretroviral treatment in a national cohort of pregnant women with HIV: overall rates and differences according to nationalityLipodystrophy is an independent predictor of hypertriglyceridemia during pregnancy in HIV-infected womenPneumocystis carinii infection in young non-immunosuppressed rabbits. Kinetics of infection and of the primary specific immune responseTyping with internal transcribed spacer regions of Pneumocystis carinii from AIDS patients with recurrent pneumoniaNon specific PCR products using rat-derivedPneumocystis cariniidihydrofolate reductase gene-specific primers in DNA amplification of human respiratory samplesCardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients
P50
Q24798930-D250A9CF-BA6D-4B5C-8101-1CCF2B64640AQ31033395-80C2FD09-B6A9-45CB-A0D0-9C2E8971E7CAQ33591573-5192246F-D087-49F4-844C-DC2FD3E4678CQ35069318-DA5D9B64-2CED-45D5-A38F-327D29C6D911Q35445035-53F06BA1-9E5E-4B72-937E-3788FDC816BEQ38440876-09EFA56C-DAC2-4552-B425-687632F10831Q38450147-93B72455-7617-4EC9-8ECE-FA693B0AAAC9Q40138414-0A003E3A-65CD-420E-83B1-5202853E1810Q40568140-11BC6000-6256-4D00-A3E2-221622E55B0EQ40998601-68D6DC03-4EE6-45EB-8646-C0CAA60B800BQ42235471-899E5760-D28D-4357-AE1C-EF41F12B327CQ42239100-E978FD71-0A62-448A-BDE2-3825C09B08C1Q42255965-28827769-5D4F-4629-85EA-E4F308F2395FQ42276740-E74165C3-D8D8-4524-B06F-B82BD4DC6223Q42994549-9E1BAFC1-4CBB-45EB-81F9-864065533763Q43157237-A7D9584E-1CF8-46E3-8715-75478E63399BQ43252942-2F0F2398-46D7-4E8D-8F73-3EEE4F3BB804Q43864153-45772F13-CBEF-4523-997C-BA09ADA22368Q44086184-240743F5-E082-4037-90CD-8B2216CF696FQ44152422-87298C6D-C3A3-444C-B2CA-C81C6FDABA93Q44873352-DF51C80B-847F-43C2-9835-D3FD2A839097Q45391845-E96E3114-3E84-4E09-BF95-9E65C0789184Q45407234-BE714457-31B7-4925-A7A1-84D334B7ADD4Q45414658-EA03652A-0DB1-45BF-AC9B-F674EB5B8C32Q45731225-4ED56BA3-3C7F-4E00-9EC8-B16481226F27Q45842769-8E502CA2-D9E8-4C66-8FF4-8566409F1669Q46792927-60466F3F-5480-4B49-B2B9-BA2FFDF33537Q50142088-1CC26969-B1FA-4716-B02C-2B19DFCC4B41Q51363612-1FE07DAA-381B-4695-B8F8-5EC1CF348F1DQ51486907-4409D7B4-4326-4792-A0FA-7343E4638664Q51803108-37314622-5C4F-48A3-93DD-95B5227FCE5BQ56880892-CE5D71B9-C00E-4DBC-86F7-44DC0EEF94A7Q56880897-E7C57CC4-4B3D-4B94-9C5D-39971A0F799EQ57451047-BF178C5C-1068-4613-9A7C-DDFD5C1BA3F7Q58798108-FBACF62C-D7F6-4080-9447-EAE6DDAED877Q58798122-0E831285-1FF6-4056-983C-3DFBE210537EQ59296296-E74826F0-BFB5-4CAA-8671-AD30E038F673Q59296298-5474845A-E56A-418F-875A-CEE375340A6CQ59296301-998AE245-8EDB-4575-9440-A256B769784DQ60625464-3964B43E-5B0B-49AA-894B-3E302383D81F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Enrica Tamburrini
@ast
Enrica Tamburrini
@en
Enrica Tamburrini
@es
Enrica Tamburrini
@nl
type
label
Enrica Tamburrini
@ast
Enrica Tamburrini
@en
Enrica Tamburrini
@es
Enrica Tamburrini
@nl
prefLabel
Enrica Tamburrini
@ast
Enrica Tamburrini
@en
Enrica Tamburrini
@es
Enrica Tamburrini
@nl
P106
P1153
7005293599
P21
P31
P496
0000-0003-4930-426X